Castle promotes positive melanoma Dx data at ASCO; UPS seeks China med tech shipping business;

@FierceMedDev: Mayo Clinic: Metabolomics could be key to early Alzheimer's blood Dx test. Article | Follow @FierceMedDev

@DamianFierce: Patient selection, biomarkers are key to cancer R&D, Quintiles says. Story | Follow @DamianFierce

@MichaelGFierce: Medtronic triggers summer PMA process for drug-eluting balloon. More | Follow @MichaelGFierce

> Castle Biosciences promoted positive data at ASCO this week regarding its new DecisionDx-Melanoma test and said it had also released the diagnostic for physician use. Item

> ArtVentive Medical Group in California won a CE mark for its new peripheral vascular enoluminal occlusion system. Item

> Cochlear's American division won FDA approval for a new behind-the-ear accessory designed to help waterproof a cochlear implant so a patient can go swimming. Item

> The scandal in France over the wide use of substandard breast implants made by Poly Implant Prosthese points to device implant regulatory inconsistencies around the world that could lead to future safety scandals. Story

> Robotic surgery is on the rise, WGN radio reports. Interview

> Startup ZSX Medical pulled in $1.4 million in a first round of financing designed to fuel development of a bioabsorbable device that helps close wounds from laparoscopic hysterectomies. Story

> UPS is expanding in China so it can handle the country's booming demand for medical devices, equipment and products. Story

Biotech News

@FierceBiotech: PR: 1st clinical data presented with ImmunoGen's IMGN853, potential new ovarian cancer therapy. Release | Follow @FierceBiotech

@JohnCFierce: GlaxoSmithKline grabs PhII rheumatoid arthritis drug in MorphoSys deal. Article | Follow @JohnCFierce

@RyanMFierce: Monday at ASCO marked by bad news from $SNY, $LLY after feel-good weekend for $MRK, $BMY. | Follow @RyanMFierce

@EmilyMFierce: New agent stops replication of hep C virus in preclinical studies. Article | Follow @EmilyMFierce

> Boehringer delivers small survival benefit for lung cancer patients. Story

> Clovis soars on upbeat signs of efficacy for targeted cancer drugs. News

> ASCO confab highlights immunotherapies, 'breakthrough' drugs and small victories. More

Pharma News

@FiercePharma: In which hep C drugs Incivek and Victrelis go from hit to dud in two years. Report | Follow @FiercePharma

@EricPFierce: Dr. Reddy's, Fujifilm pull plug on Japanese joint venture. Article | Follow @EricPFierce

@CarlyHFierce: ICYMI Friday: Sun Pharma eyeing takeover of Sweden's Meda. Story | Follow @CarlyHFierce

> ASCO: Bayer's Nexavar gets boost, while Roche's Avastin reports mixed. Roundup

> Lilly blockbuster Alimta burned by more disappointing news. More

> KV rebounds as docs get uneasy about compounded drugs. Story

CRO News

> Quintiles: Patient selection, biomarkers key to cancer R&D. Report

> Unither buys UCB's NY plant. Item

> DKSH ups South Korean presence. Story

> QPS teams with Hepregen for DMPK. More

> UPM buys Pfizer's TN plant, snags CMO deal. Article

Biotech IT News

> Software-backed MTI system spots breast tumors. Item

> OpGen teams with bioinformatics outfit to combat outbreaks. Story

> BT and Accelrys deepen ties for cloud computing in life sciences. Report

> Eli Lilly backs mobile app for cancer docs. News

> Boehringer, Eli Lilly aim to educate diabetics with iPad game. Article